Loading...
Header Logo
Keywords
Last Name

Connection

Search Results to Herbert Lloyd Bonkovsky, M.D.

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Bonkovsky, Herbert

Item TypeName
Concept Hepatitis B, Chronic
Concept Hepatitis C, Chronic
Academic Article High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.
Academic Article Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy.
Academic Article A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C.
Academic Article Mixed cryoglobulinemia in chronic hepatitis C infection. A clinicopathologic analysis of 10 cases and review of recent literature.
Academic Article High-dose interferon-alpha 2b for re-treatment of nonresponders or relapsing patients with chronic hepatitis C. A controlled randomized trial.
Academic Article Inflammatory markers in chronic hepatitis C.
Academic Article Frequency and distribution of DNA fragmentation as a marker of cell death in chronic liver diseases.
Academic Article Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C.
Academic Article Enhanced phenotypic expression of alpha-1-antitrypsin deficiency in an MZ heterozygote with chronic hepatitis C.
Academic Article Inefficient recognition of autologous viral sequences by intrahepatic hepatitis C virus-specific cytotoxic T lymphocytes in chronically infected subjects.
Academic Article Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.
Academic Article IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy.
Academic Article Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial.
Academic Article Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial.
Academic Article Outcomes research in chronic viral hepatitis C: effects of interferon therapy.
Academic Article Management of recurrent hepatitis C after liver transplantation: a concise review.
Academic Article Comparative effects of different doses of ribavirin plus interferon-alpha2b for therapy of chronic hepatitis C: results of a controlled, randomized trial.
Academic Article Iron as a comorbid factor in chronic viral hepatitis.
Academic Article Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.
Academic Article Iron as a co-morbid factor in nonhemochromatotic liver disease.
Academic Article Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.
Academic Article Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.
Academic Article Hemochromatosis mutations in Iranians with hepatitis B virus infection.
Academic Article Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C.
Academic Article Evolution of the intrahepatic T cell repertoire during chronic hepatitis C virus infection.
Academic Article Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.
Academic Article No role of the -2518 promoter polymorphism of monocyte chemotactic protein-1 in chronic hepatitis C.
Academic Article HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.
Academic Article Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
Academic Article Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.
Academic Article Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.
Academic Article Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.
Academic Article Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin.
Academic Article Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials.
Academic Article Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.
Academic Article Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
Academic Article Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C.
Academic Article DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial.
Academic Article Efficacy and safety of peginterferon alfa-2a/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration.
Academic Article Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.
Academic Article Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis.
Academic Article Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
Academic Article Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
Academic Article Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.
Academic Article Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
Academic Article Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
Academic Article Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.
Academic Article Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial.
Academic Article Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.
Academic Article Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C.
Academic Article Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review.
Academic Article Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.
Academic Article Genetic variations in heme oxygenase-1 and chronic hepatitis.
Academic Article Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.
Academic Article Outcome of sustained virological responders with histologically advanced chronic hepatitis C.
Academic Article Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.
Academic Article Parallel microRNA and mRNA expression profiling of (genotype 1b) human hepatoma cells expressing hepatitis C virus.
Academic Article Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.
Academic Article Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C.
Academic Article Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.
Academic Article Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.
Academic Article A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.
Academic Article An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C.
Academic Article Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C.
Academic Article YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C.
Academic Article A naturally occurring human/hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell culture.
Academic Article Chinese medicine for treatment of chronic hepatitis B.
Academic Article Hepatitis C, porphyria cutanea tarda and liver iron: an update.
Academic Article Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis C.
Academic Article Risk factors for porphyria cutanea tarda -the iron/HFE connection.
Academic Article Cytoskeletal proteins: shaping progression of hepatitis C virus-induced liver disease.
Academic Article Chronic hepatitis E with neurologic manifestations and rapid progression of liver fibrosis in a liver transplant recipient.
Academic Article MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA.
Academic Article Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
Grant HEPATITIS C CLINICAL TRIAL-CLINICAL CENTERS

Search Criteria
  • Hepatitis C Chronic